Hippo ERcast February 2025

February Intro: Work-Life Balance

Work-life balance in emergency medicine is less about a fixed number of shifts and more about sustaining excellent patient care over time. Training, early career practice, and long-term wellness create real friction points around standards, staffing, and family life. Work-Life Balance in Emergency Medicine Excellence over shift counts: Clinical excellence is not anchored to a magic shifts-per-month number; it depends on ongoing engagement with the work, deliberate reflection, and maintaining a high standard of emergency care. Training versus wellness goals: Residency and fellowship are for attaining durable standards of excellent emergency care, not for optimizing lifestyle first, though trainee wellness still matters and that tension is worth hearing in the episode. Long-view self assessment: A month-to-month lens can be more honest than judging a rough day or week, helping clinicians separate transient overload from a true mismatch between work demands and life capacity. Nonwork sources of overload: What feels like burnout is often amplified by complicated stressors outside medicine, and mislabeling every strain as a work problem can obscure the fixes that actually matter. Reducing career friction points: Schedule design, family time, learner engagement, and spending habits all shape whether work feels sustainable; we get into the practical tradeoffs in the chapter.

Rational use of DOACs with Deloughery

Direct oral anticoagulants have largely displaced warfarin because they are easier to use and carry less intracranial bleeding. The harder questions are renal disease, liver disease, breakthrough thrombosis, and when cost or valve pathology still makes warfarin the right call. Choosing and dosing DOACs DOACs over warfarin: DOACs generally beat warfarin on practicality and safety, with a lower intracranial hemorrhage burden and less day-to-day INR volatility from diet and drug interactions. Renal disease reality: Dialysis is not an automatic reason to avoid a DOAC; apixaban is often workable, while warfarin can be especially difficult in ESRD because low vitamin K states destabilize INR control. Apixaban liver fit: Most patients with liver disease can still take apixaban, and Child-Pugh class B is the key zone where it remains the only DOAC commonly kept on the table. Dose reduction boundaries: Extended-phase VTE therapy can often step down after 6 months if the patient is stable, but atrial fibrillation and cancer-associated thrombosis generally stay on full-dose anticoagulation. Absolute DOAC exclusions: Mechanical heart valves, triple-positive antiphospholipid syndrome, and rheumatic valvular disease remain major reasons to avoid DOACs. We get into the practical why in the episode. Breakthrough clot and follow-up Breakthrough clot framing: A recurrent clot on a DOAC is nonadherence until proven otherwise; the first move is a careful medication timeline plus anticoagulant levels when available. Missed dose red flag: Only one or two missed doses should still make you uneasy, because that pattern can justify pivoting to low molecular weight heparin rather than casually resuming outpatient therapy. Restarting after underdosing: If the patient has been underdosed or off therapy for a meaningful stretch and remains stable, restarting the original full-intensity DOAC regimen is often reasonable. Post PE syndrome: About half of patients have persistent chest pain or dyspnea for months after pulmonary embolism despite clot resolution, a pattern worth validating rather than reflexively labeling treatment failure. Symptom timeline counseling: Post-PE symptoms can last up to a year even with a reassuring echo, and that counseling point alone can prevent a lot of unnecessary alarm. We cover the bedside language in the chapter. When warfarin still matters Cost-driven warfarin use: The strongest modern indication for warfarin is sometimes affordability, because an effective drug the patient cannot obtain is not an effective anticoagulation plan. Access before prescribing: If warfarin is the only viable option, reliable transportation and quick access to INR follow-up are mandatory practical checks before discharge. DOAC affordability workarounds: Pharmacists, social workers, and manufacturer copay programs can salvage DOAC access more often than clinicians assume, and low molecular weight heparin may be the cheaper fallback in some settings. Long-term warfarin costs: Warfarin brings hidden burdens beyond INR checks, including greater osteoporosis risk over time and more medication and diet interference than DOAC therapy.

What You Need to Know About LVAD Alarms and Malfunction

LVAD emergencies are usually not pump failure; about 90% of ED visits in patients with LVADs are for non-device problems. The bedside approach starts with a precordial hum, battery and controller checks, and alarm interpretation that can quickly separate suction events, pump thrombosis, and mechanical failure. LVAD bedside assessment and alarms Core ED reality check: Most LVAD patients are critically ill heart-failure patients, but roughly 90% of presenting complaints are unrelated to LVAD malfunction, so keep a broad emergency differential alongside the device evaluation. ABCs with a hum: A continuous precordial mechanical hum is the quickest bedside sign that the pump is running; absent hum should immediately raise concern for mechanical failure. Battery and controller basics: Power comes from two or more rechargeable battery packs with about 16-18 hours of life, and patients need their own charger for wall power in the ED. Patient-specific baseline metrics: Controller numbers matter most when compared with the patient’s usual baseline, and patients themselves can often tell you which alarm fired and what is abnormal. Alarm pattern recognition: Low-flow alarms point toward suction events, while high power with low flow suggests pump thrombosis. We walk through how to read those patterns in the episode. Major LVAD malfunctions Suction event physiology: A suction or suck-down event is a preload problem: the LV collapses against the inflow cannula, causing transient obstruction, low-flow alarms, and sometimes syncope. Reversible precipitants to find: Think hypovolemia, tamponade, massive PE, tension pneumothorax, or RV failure with septal shift; treatment is fixing the cause rather than changing the LVAD yourself. Mechanical failure red flag: Loss of hum suggests pump failure or power interruption from battery, controller, cable, or driveline problems, and unstable patients may need immediate hemodynamic support. Restarting a stopped pump: Pump interruption carries thrombus risk, so stable patients should have the LVAD team involved before restart, while unstable patients may need restart first despite that hazard. Pump thrombosis pattern: Pump thrombosis classically produces high power and low flow because the device is working harder against obstruction, often with hemolysis clues such as dark urine and elevated LDH. Driveline fracture clues: Low flow, low speed, or low power alarms can indicate driveline fracture; AP and lateral chest-abdomen films help, and driveline manipulation should be specialist-guided. The stabilization nuance is worth hearing in the chapter.

Lit Matters 1: Which Virus Does the Child in Front of Me Have, and Does it Matter?

Broad respiratory viral PCR testing rarely changes emergency department management for uncomplicated pediatric fever, cough, bronchiolitis, or viral URI. In this pediatric ED study, comprehensive respiratory viral panels were linked to higher charges, longer length of stay, and no meaningful improvement in outcomes. Pediatric Respiratory Viral Panel Testing Limited management impact: Comprehensive respiratory viral panels did not move care for typical pediatric URI presentations; bedside severity assessment mattered more than identifying rhinovirus, RSV, or another named virus. Higher patient charges: CRVP testing was associated with a major jump in total charges, about $643 versus $295, without any cost advantage when the panel came back positive. Longer emergency stay: Testing roughly doubled ED length of stay, from about 2 hours to 4 hours, a throughput penalty that matters during winter surge. We get into the operational implications in the episode. No antibiotic reassurance: Antimicrobial use was actually higher in the tested group regardless of whether the panel was positive, undercutting the idea that more viral data automatically reduces unnecessary treatment. Best use-case framing: For the child who looks like an uncomplicated viral illness, the useful split is sick versus not sick, not which virus is on the swab; the exceptions are worth hearing in the chapter.

Non-LVAD-Specific Problems in LVAD Patients

LVAD patients can look deceptively stable during serious non-device emergencies because the pump supports the left ventricle while the right ventricle remains vulnerable. In arrhythmia, shock, GI bleeding, stroke, and sepsis, bedside clues like high-flow or low-flow alarms can change the differential fast. Arrhythmias and Hemodynamic Collapse Well-appearing malignant rhythms: LVAD support can mask dangerous dysrhythmias, so patients with ventricular arrhythmias may look surprisingly well until right-sided failure and pump failure declare themselves. Standard rhythm treatment: Treat unstable arrhythmias as you would in any other patient, including cardioversion or defibrillation, while keeping pads off the pump hardware. Reversible trigger search: Hyperkalemia and STEMI still matter in LVAD patients with dysrhythmia, because the device does not remove the usual causes of sudden decompensation. Perfusion-based arrest decisions: Cardiac arrest assessment hinges on perfusion markers rather than pulse alone, with MAP and end-tidal CO2 helping decide when CPR is truly needed. We walk through that bedside logic in the episode. Aortic Regurgitation and RV Failure High-flow shock physiology: Aortic regurgitation can create a useless recirculation loop where LVAD outflow falls back across the aortic valve, raising displayed flow while systemic perfusion worsens. High-flow alarm warning: An ill-appearing LVAD patient with a high-flow alarm should trigger concern for severe aortic regurgitation, not reassurance that cardiac output is adequate. Bedside echo clue: Point-of-care echo showing a regurgitant jet through the aortic valve is the key bedside finding when controller numbers do not match the clinical picture. Unprotected right ventricle: Right ventricular failure is a major driver of morbidity and mortality after LVAD implantation because the device unloads only the left ventricle. Low-flow preload problem: RV failure often presents with a low-flow alarm from reduced preload to the pump, along with shock, congestion, and rising lactate, creatinine, or liver enzymes. Bleeding, Stroke, and Blood Pressure Common GI bleeding site: The GI tract is the most frequent bleeding source in LVAD patients, driven by anticoagulation plus continuous-flow effects like von Willebrand multimer shear and angiodysplasia. Early hemostatic moves: Initial management centers on hemodynamic stabilization, blood products as needed, and agents such as high-dose PPI, octreotide, and desmopressin. Anticoagulation reversal threshold: Life-threatening hemorrhage may require early reversal with vitamin K and 4-factor PCC, while avoiding large-volume resuscitation that can worsen heart failure. We get into the tradeoffs in the chapter. Stroke treatment pivot: Stroke is a major late cause of death after LVAD implantation, and thrombolytics are generally contraindicated, making endovascular therapy the preferred reperfusion path when feasible. Afterload sensitivity: Hypertensive emergency matters because LVAD patients are highly sensitive to afterload, but overly aggressive blood pressure reduction can also be harmful.

Aortic Trauma

Blunt traumatic aortic injury is a high-mortality deceleration injury, classically at the aortic isthmus just distal to the left subclavian artery. Management hinges on injury grade, hemodynamics, and associated trauma, with early CT review and prompt surgical coordination shaping outcomes. Blunt Traumatic Aortic Injury Classic injury mechanism: Rapid deceleration from motor vehicle collision is the leading cause, with the aortic isthmus the classic tear site because it is tethered at a relatively fixed point. Grade-based injury pattern: The key spectrum runs from grade 1 intimal tear to grade 4 rupture or frank extravasation, and that grading framework drives urgency and blood pressure strategy. Anti-impulse first-line therapy: For grade 1 through 3 injuries, IV beta blockade is the initial move, targeting systolic blood pressure under 140 mm Hg to reduce shear stress on the injured aorta. Unstable rupture physiology: Grade 4 injury is treated with permissive hypotension, blood products, and IV fluids to maintain perfusion rather than reflex beta blockade, a distinction we get into in the episode. Early CT image review: Personally reviewing the initial CT early can reveal high-risk features and associated injuries fast enough to engage vascular or thoracic surgery before delays compound risk. Modern repair logistics: More than 90% of repairs are now endovascular with femoral access and stent graft exclusion, and many cases can be completed in roughly 15 to 20 minutes once underway.

Lit Matters 2: Speed Matters… or Does it? How Fast is Fast Enough for Antibiotics in Septic Children?

Pediatric sepsis care still favors early antibiotics, but this large multicenter study suggests sepsis-attributable mortality does not begin to climb until antibiotic delay extends well beyond the familiar 3-hour benchmark. In children with suspected sepsis, diagnosis, resuscitation, source control, and disposition remain at least as important as reflexively pushing antibiotics first. Pediatric Sepsis Antibiotic Timing Multicenter mortality inflection: Across 51 US children's hospitals, sepsis-related 3-day mortality began to rise at 330 minutes from sepsis recognition, a much later signal than many clinicians would expect. Guideline tension point: Current pediatric sepsis guidance still cites antibiotics within 1 hour for shock and within 3 hours for sepsis, but this dataset challenges how rigidly that 3-hour rule should be applied. Early treatment confounding: Children treated in the first 29 minutes had higher mortality than those treated later, a classic marker of confounding by indication rather than proof that faster antibiotics are harmful. Outcome pattern nuance: Delayed antibiotics beyond the inflection point were linked to higher 3-day and 30-day sepsis mortality, yet ICU admission, ventilator use, and vasoactive support did not clearly differ. Recognition time anchor: The study used First Time Zero within 1 hour of ED arrival as the sepsis recognition anchor, an important operational detail when interpreting any time-to-antibiotic target. We get into why that definition matters in the episode. Practice-changing takeaway: Antibiotics still matter in pediatric sepsis, but the bigger bedside priority may be targeted diagnosis, resuscitation, and source control instead of blindly front-loading antimicrobials.

Diverticulitis Updates

Acute diverticulitis is increasingly managed as an inflammatory illness, not an automatic antibiotic diagnosis. CT abdomen and pelvis with IV contrast remains the reference imaging test for complicated disease, but selected well-appearing patients with suspected uncomplicated diverticulitis may not need CT or antibiotics. Diverticulitis Evaluation and Imaging Clinical diagnosis limits: History and exam alone are unreliable, correctly identifying diverticulitis in only about 25% to 75% of cases, so the real bedside task is separating uncomplicated disease from occult complication. Helpful bedside findings: Left lower quadrant tenderness is the strongest classic exam clue, with a positive likelihood ratio around 10, while peritonitis should immediately raise concern for perforation or other complicated disease. Inflammatory marker signal: CRP is more useful than the white count for risk stratification; a CRP above 50 mg/L strongly points toward complicated diverticulitis, while isolated labs perform poorly on their own. CT as reference test: CT abdomen and pelvis with IV contrast is the go-to study, with sensitivity above 94% and specificity near 99% for both uncomplicated and complicated diverticulitis. When imaging may wait: A well-appearing, immunocompetent patient with left lower quadrant pain that feels like a prior uncomplicated episode may not need immediate CT. We get into the patient-selection nuance in the episode. Antibiotics, Disposition, and Follow-up Inflammation over infection: Uncomplicated diverticulitis often behaves as a primarily inflammatory process, and multiple randomized trials plus meta-analysis found no clear outcome advantage to routine antibiotics in selected patients. Who still needs antibiotics: Complicated diverticulitis, microperforation, sepsis, immunocompromise, or major comorbidity still push management toward antibiotics and closer observation rather than minimalist outpatient care. Abscess size matters: Small abscesses under 3 to 4 cm often improve with antibiotics alone, while larger collections or failures to improve are the group where drainage enters the conversation. Admission versus discharge: Uncomplicated diverticulitis can usually go home with close follow-up if the patient tolerates oral intake and remains stable; complicated disease needs admission and surgical involvement. Colonoscopy after recovery: After symptoms resolve, complicated diverticulitis warrants colonoscopy because up to 10% of cases have an underlying colorectal malignancy. That follow-up distinction is worth hearing in the chapter. Recurrence trajectory: Recurrence after a first episode is modest at roughly 20% by 10 years, but after a second episode the 10-year recurrence risk rises to about 50%, which changes follow-up conversations.

Lit Matters 3: Defining Pediatric Sepsis and Septic Shock

Pediatric sepsis is now moving toward an organ dysfunction definition rather than older SIRS-based criteria. The 2024 Phoenix criteria use four organ systems to identify pediatric sepsis and septic shock, with stronger mortality prediction than prior pediatric consensus definitions but limited usefulness in the first minutes of ED care. Phoenix Criteria for Pediatric Sepsis Organ dysfunction framework: Phoenix defines pediatric sepsis around life-threatening organ dysfunction with suspected infection, moving beyond the older 2005 IPSCC SIRS-style approach. Four-system core model: The best-performing version used respiratory, cardiovascular, coagulation, and neurologic dysfunction rather than an eight-system model, a useful simplification for pediatric sepsis language. Mortality-linked score performance: Mortality rose as the Phoenix Sepsis Score increased in both high- and low-resource settings, supporting the score as a risk-stratification tool rather than a bedside gestalt replacement. Sepsis and shock thresholds: Phoenix labels sepsis as suspected infection plus a score above a defined cutoff, and septic shock as sepsis with at least one cardiovascular point. We walk through what counts toward those points in the episode. External validation across settings: The criteria were derived and tested across hospitals in the U.S., Bangladesh, Colombia, China, and Kenya, which strengthens generalizability across very different resource environments. What It Means in Emergency Care Better than prior definitions: Phoenix outperformed IPSCC definitions on positive predictive value and sensitivity for in-hospital death, early death, and ECMO, giving clinicians a more credible common language. Not an initial triage tool: The score depends on labs, ventilatory data, and hemodynamic variables that are often unavailable during the first ED assessment, so it is poorly suited to immediate recognition. Post-resuscitation use case: Its practical niche is after initial stabilization, especially for boarding patients, ICU handoff, or EMR-based screening once the necessary data have populated. That workflow fit is worth hearing in the chapter. Common language advantage: Even if it does not drive the first antibiotics or fluids, Phoenix may standardize how pediatric sepsis severity is described across the ED, ICU, and research settings.